SHANGHAI JUNSHI BIOSCIENCES CO., LTD. · 君实生物
Last · HKSEHK$16.18-0.64 (-3.80%)close · yahoo · 11h ago
Market capHK$16.6B260.3M sh
P/E · TTM-36.0fwd 81.1 · eps -0.45 · loss
Beta0.52vs S&P 500
Div yield0.00%annual · TTM
52w range
HK$15.25HK$30.80
Volume1.8Msession
| Revenue | ¥2.2B |
|---|---|
| Operating income | ¥-19.0M |
| Net income | ¥21.7M |
| Free cash flow | ¥-1.1B |
| Operating margin | -0.8% |
| Net margin | 1.0% |
| Return on equity | 0.4% |
| Period | TTM 2026-06-30 |
Loading chart…
OpenFilings analyst
Our analyst
From latest 10-K · 2026-03-14
- Operating Cf Burn
- Net Margin Sharply Negative
- Accumulated Deficit High
- Rd Intensity High
Red flags
- Operating Cf Burn — Negative operating cash flow
- Net Margin Sharply Negative — Net margin -35.0%
- Accumulated Deficit High — Accumulated deficit / equity 186%
- Rd Intensity High — R&D/Revenue 53.7%
Upcoming earnings
9:10 AM UTC+1
Period
Sep 2026
Est. EPS
—
Est. revenue
0
Press & signals
- GlobeNewswire
Junshi Biosciences Announces 2026 Interim Financial Results and Provides Corporate Updates
Documents
FormReporting forFiledFlags